tirzepatide news update Eli Lilly's showed positive results in late-stage trial as treatment for heart failure Breaking News: OFA Challenges FDA

Lilly urged the FDA to recall all compounded tirzepatide products containing B12 additives

The term microdosing in this context isnt sanctioned by health authorities, but its gaining popularity online among people who, for various reasons, want to tweak their dosage

GLP-1 agonists are a class of prescription medications used to help treat type 2 diabetes, and in some cases, manage obesity

titrate up) every 30 days or so until you find a dosage that adequately controls your blood sugar levels

The impact of GLP-1 receptor agonist shortages on glycaemic control: findings from an Australian specialist diabetes clinic